Log in
Diagnostic Radiology · Diagnostic Radiology of the Abdominal Organs

Splenic lymphoma

*Splenic Lymphoma*

Splenic lymphoma is a malignant neoplastic lesion of the organ that requires a comprehensive approach in diagnostic radiology. Ultrasound, contrast-enhanced computed tomography (CT), and PET/CT are used to identify pathological foci, while various methods have different sensitivities.

Main featureMultiple focal lesions in the parenchyma
ImportantUltrasound and PET/CT detect more lesions than conventional CT
UltrasoundHeterogeneous masses with reduced echogenicity
3 min readFor medical studentsUpdated Sep 25, 2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Imaging findings in lymphoma

Diagnosis of splenic lymphoma is based on detecting structural changes in the organ parenchyma. Depending on the chosen imaging method, the following features are visualized:

  • Ultrasound (US): multiple masses are identified in the splenic tissue. They have an irregular shape, heterogeneous structure, and areas with reduced echogenicity (reduced echo reflectivity).
  • Computed tomography (CT): with contrast enhancement (post-contrast CT), the lesions appear as mildly heterogeneous masses with decreased density (low-attenuation lesion) compared to normal tissue.
  • 18F-FDG PET/CT: tumor lesions demonstrate high metabolic activity, actively taking up the radiopharmaceutical (FDG avid).

Comparison of imaging modalities

A key feature of the radiological diagnosis of splenic lymphoma is the varying sensitivity of the methods used.

Practice shows that ultrasound and positron emission tomography (PET/CT) are able to detect a greater number of pathological lesions in the organ. Conventional computed tomography (CT), despite contrast enhancement, may miss some small or isodense lesions, making it less informative in assessing the true extent of the process compared to combined and ultrasound techniques.

Test your knowledge on the topicTasks from the "Diagnostic Radiology" course bank — instant answers and explanations.

Differential diagnosis

When focal or diffuse changes in the spleen are detected, lymphoma must be differentiated from a number of other pathologies described in diagnostic radiology:

  • Melanoma metastases: on portal venous phase CT, they also present as low-density foci, and on PET/CT they actively take up FDG.
  • Sarcoidosis: causes splenomegaly (homogeneous on unenhanced CT). In the delayed phase, weakly enhancing 2–3 cm nodules are visible.
  • Amyloidosis: can occur in nodular or diffuse forms. It is characterized by decreased density on CT and a high probability of organ rupture due to vascular fragility.
  • Extramedullary hematopoiesis: can form tumor-mimicking masses. The MRI signal depends on the "age" of the lesion (active vs. old).

Briefly: answers to topical questions

How to distinguish extramedullary hematopoiesis from splenic lymphoma on MRI?

It is impossible to reliably differentiate extramedullary hematopoiesis from lymphomatous involvement of the spleen on MRI, especially in infiltrative lymphoma, because normal and lymphoma-infiltrated tissue may have similar signal intensity.

In focal lesions:

SignLymphomatous involvement of the spleenExtramedullary hematopoiesis
T1-weighted imagingSlightly hypointense signalIntermediate signal in active lesions or hypointense signal in old lesions
T2-weighted imagingHyperintense signalHigh signal in active lesions or hypointense signal in old lesions
Contrast enhancementThe referenced sources do not specify the contrast enhancement characteristics of MRI lesionsActive lesions enhance with contrast, while old lesions may not enhance

Class and exam questions

Which method best detects the number of lesions in splenic lymphoma?

Ultrasound and PET/CT show a greater number of tumor nodes in the splenic parenchyma compared to computed tomography.

What do lymphoma lesions look like on contrast-enhanced CT?

They are visualized as mildly heterogeneous masses with decreased density (low-attenuation lesions).

Does splenic lymphoma take up contrast on PET/CT?

Yes, lymphoma lesions actively take up fluorodeoxyglucose (18F-FDG), demonstrating high metabolic activity.

Unclear? Ask the AIThe AI tutor has reviewed the material on "Splenic lymphoma" and will explain it in simple terms.

What else to study on this topic

  • MRI findings of Gandy-Gamna bodies in portal hypertension
  • Diagnosis of splenic amyloidosis and the risks of rupture
  • CT and MRI manifestations of hemosiderosis
  • Gaucher disease: MRI signs of glucocerebroside accumulation
  • Extramedullary hematopoiesis: differentiation of active and old lesions on MRI

Master the entire topic in the "Diagnostic Radiology" course

This is a summary. The course covers everything tested in classes and exams.

  • Complete study guide on "Splenic lymphoma" and 2,199 more subject pages
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 10 video lessons on the subject

Other topics in the section "Diagnostic Radiology of the Abdominal Organs"

Entire section "Diagnostic Radiology of the Abdominal Organs"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.